Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Bio Key International (BKYI) over the last 17 years, with Q3 2025 value amounting to 57.57%.

  • Bio Key International's EBIT Margin fell 305100.0% to 57.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 61.5%, marking a year-over-year increase of 134700.0%. This contributed to the annual value of 57.88% for FY2024, which is 559300.0% up from last year.
  • As of Q3 2025, Bio Key International's EBIT Margin stood at 57.57%, which was down 305100.0% from 63.87% recorded in Q2 2025.
  • In the past 5 years, Bio Key International's EBIT Margin registered a high of 23.33% during Q1 2024, and its lowest value of 284.13% during Q4 2022.
  • Its 5-year average for EBIT Margin is 102.07%, with a median of 80.52% in 2023.
  • As far as peak fluctuations go, Bio Key International's EBIT Margin surged by 3481300bps in 2021, and later crashed by -953200bps in 2022.
  • Over the past 5 years, Bio Key International's EBIT Margin (Quarter) stood at 213.85% in 2021, then crashed by -33bps to 284.13% in 2022, then skyrocketed by 47bps to 149.24% in 2023, then soared by 42bps to 86.69% in 2024, then soared by 34bps to 57.57% in 2025.
  • Its EBIT Margin was 57.57% in Q3 2025, compared to 63.87% in Q2 2025 and 39.86% in Q1 2025.